Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03981796 |
|---|---|
| Brief Title: | A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer (RUBY) |
| First Submitted : | May 31, 2019 |
| First Submitted that Met QC Criteria : | June 7, 2019 |
| First Posted : | June 11, 2019 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |